Patents Assigned to Chromagen
-
Patent number: 9028064Abstract: Methods of fabricating and prescribing lenses suitable for color blindness and dyslexia correction are disclosed. The corrective lens may be formed of an optically transparent base material, which is tinted to a desired color for correction by immersion in a colorant dye. The color tinted lens is then tinted by a neutral tint dye to render the lens observable as a regular corrective lens. Prescription of such lenses may be based on a dynamically balanced, or haploscopic, fashion of prescription that comprises selecting a first visual filter from a set of sixteen filters and a second visual filter from the remaining set of fifteen filters, the first for the dominant eye and the second for non-dominant eye.Type: GrantFiled: June 25, 2012Date of Patent: May 12, 2015Assignee: ChromaGen Vision LLCInventor: David Andrew Harris
-
Patent number: 8414127Abstract: Methods of fabricating and prescribing lenses suitable for color blindness and dyslexia correction are disclosed. The corrective lens may be formed of an optically transparent base material, which is tinted to a desired color for correction by immersion in a colorant dye. The color tinted lens is then tinted by a neutral tint dye to render the lens observable as a regular corrective lens. Prescription of such lenses may be based on a dynamically balanced, or haploscopic, fashion of prescription that comprises selecting a first visual filter from a set of sixteen filters and a second visual filter from the remaining set of fifteen filters, the first for the dominant eye and the second for non-dominant eye.Type: GrantFiled: March 31, 2011Date of Patent: April 9, 2013Assignee: ChromaGen Vision LLCInventor: David Andrew Harris
-
Publication number: 20120273110Abstract: Methods of fabricating and prescribing lenses suitable for color blindness and dyslexia correction are disclosed. The corrective lens may be formed of an optically transparent base material, which is tinted to a desired color for correction by immersion in a colorant dye. The color tinted lens is then tinted by a neutral tint dye to render the lens observable as a regular corrective lens. Prescription of such lenses may be based on a dynamically balanced, or haploscopic, fashion of prescription that comprises selecting a first visual filter from a set of sixteen filters and a second visual filter from the remaining set of fifteen filters, the first for the dominant eye and the second for non-dominant eye.Type: ApplicationFiled: June 25, 2012Publication date: November 1, 2012Applicant: ChromaGen Vision LLCInventor: David Andrew Harris
-
Publication number: 20110176105Abstract: Methods of fabricating and prescribing lenses suitable for color blindness and dyslexia correction are disclosed. The corrective lens may be formed of an optically transparent base material, which is tinted to a desired color for correction by immersion in a colorant dye. The color tinted lens is then tinted by a neutral tint dye to render the lens observable as a regular corrective lens. Prescription of such lenses may be based on a dynamically balanced, or haploscopic, fashion of prescription that comprises selecting a first visual filter from a set of sixteen filters and a second visual filter from the remaining set of fifteen filters, the first for the dominant eye and the second for non-dominant eye.Type: ApplicationFiled: March 31, 2011Publication date: July 21, 2011Applicant: ChromaGen Vision LLCInventor: David Andrew Harris
-
Publication number: 20080225289Abstract: A fluorescence spectrophotometer system may be implemented in scanning fluorescence polarization detection applications. A wavelength and area scanning fluorescence spectrophotometer system may include a light source, an excitation double monochromator, an excitation/emission light transfer module, an emission double monochromator, a high speed timer-counter circuit board, a precision positioning apparatus for positioning a sample relative to the focal plane of the excitation light, and polarizing filters at the excitation side and the emission side. The system may be operative to analyze more than one fluorescent compound in the sample; additionally or alternatively, the system enables analysis of samples from selected ones of a plurality of samples.Type: ApplicationFiled: March 31, 2008Publication date: September 18, 2008Applicant: CHROMAGEN, INC.Inventors: Gene Gould, Michael J. Conrad
-
Patent number: 7411673Abstract: A fluorescence spectrophotometer having an excitation double monochromator, a coaxial excitation/emission light transfer module, and an emission double monochromator. Each monochromator includes a pair of holographic concave gratings mounted to precisely select a desired band of wavelengths from incoming broadband light without using other optical elements, such as mirrors. Selected excitation light is directed into a sample well by a light transfer module that includes a coaxial excitation mirror positioned to direct excitation light directly to the bottom of a well of a multi-well plate. Fluorescence emission light that exits the well opening is collected by a relatively large coaxial emission mirror. The collected emission light is wavelength selected by the emission double monochromator. Selected emission light is detected by a photodetector module.Type: GrantFiled: September 8, 2003Date of Patent: August 12, 2008Assignee: Chromagen, Inc.Inventors: Gene Gould, Michael J. Conrad
-
Patent number: 7352459Abstract: A fluorescence spectrophotometer system may be implemented in scanning fluorescence polarization detection applications. A wavelength and area scanning fluorescence spectrophotometer system may include a light source, an excitation double monochromator, an excitation/emission light transfer module, an emission double monochromator, a high speed timer-counter circuit board, a precision positioning apparatus for positioning a sample relative to the focal plane of the excitation light, and polarizing filters at the excitation side and the emission side. The system may be operative to analyze more than one fluorescent compound in the sample; additionally or alternatively, the system enables analysis of samples from selected ones of a plurality of samples.Type: GrantFiled: December 31, 2001Date of Patent: April 1, 2008Assignee: Chromagen, Inc.Inventors: Gene Gould, Michael J. Conrad
-
Patent number: 6949632Abstract: The subject invention provides compounds useful as fluorogenic substrates for the hydrolytic enzymes. Upon hydrolysis of the hydrolyzable group, a halo-pyrene substituted molecule is developed which is highly fluorescent, water soluble and exhibits several desirable characteristics, including a large Stokes' shift.Type: GrantFiled: August 27, 2002Date of Patent: September 27, 2005Assignee: Chromagen, Inc.Inventors: Michael J. Conrad, Liyan He
-
Publication number: 20040046956Abstract: A fluorescence spectrophotometer having an excitation double monochromator, a coaxial excitation/emission light transfer module, and an emission double monochromator. Each monochromator includes a pair of holographic concave gratings mounted to precisely select a desired band of wavelengths from incoming broadband light without using other optical elements, such as mirrors. Selected excitation light is directed into a sample well by a light transfer module that includes a coaxial excitation mirror positioned to direct excitation light directly to the bottom of a well of a multi-well plate. Fluorescence emission light that exits the well opening is collected by a relatively large coaxial emission mirror. The collected emission light is wavelength selected by the emission double monochromator. Selected emission light is detected by a photodetector module.Type: ApplicationFiled: September 8, 2003Publication date: March 11, 2004Applicant: Chromagen, Inc.Inventors: Gene Gould, Michael J. Conrad
-
Patent number: 6654119Abstract: A fluorescence spectrophotometer having an excitation double monochromator, a coaxial excitation/emission light transfer module, and an emission double monochromator. Each monochromator includes a pair of holographic concave gratings mounted to precisely select a desired band of wavelengths from incoming broadband light without using other optical elements, such as mirrors. Selected excitation light is directed into a sample well by a light transfer module that includes a coaxial excitation mirror positioned to direct excitation light directly to the bottom of a well of a multi-well plate. Fluorescence emission light that exits the well opening is collected by a relatively large coaxial emission mirror. The collected emission light is wavelength selected by the emission double monochromator. Selected emission light is detected by a photodetector module.Type: GrantFiled: April 20, 2000Date of Patent: November 25, 2003Assignee: Chromagen, Inc.Inventors: Gene Gould, Michael J. Conrad
-
Patent number: 6635435Abstract: The subject invention provides compounds useful as fluorogenic substrates. Upon hydrolysis of a hydrolyzable group, a halo-pyrene substituted molecule is developed which is highly fluorescent, water soluble and exhibits several desirable characteristics, including a large Stokers' shift.Type: GrantFiled: July 9, 1999Date of Patent: October 21, 2003Assignee: Chromagen, Inc.Inventors: Michael J. Conrad, Liyan He
-
Patent number: 6268132Abstract: Structural analogs of the six non-fluorescentN-nucleosides commonly found in RNA and DNA, which are inherently fluorescent under physiological conditions, are identified and methods for their preparation provided. Such analogs may be incorporated into DNA and/or RNA oligonucleotides via either enzymatic or chemical synthesis to produce fluorescent oligonucleotides having prescribed sequences. Such analogous sequences may be identical to, or the analogous complement of, template or target DNA or RNA sequences to which the fluorescent oligonucleotides can be hybridized. Methods of preparing either RNA or DNA oligonucleotide probes of the invention, intermediates used in such methods, and methods of using the probes of the invention in oligonucleotide amplification, detection, identification, and/or hybridization assays are also provided.Type: GrantFiled: March 13, 1998Date of Patent: July 31, 2001Assignee: Chromagen, Inc.Inventor: Michael J. Conrad
-
Patent number: 5763167Abstract: Structural analogs of the six non-fluorescent N-nucleosides commonly found in RNA and DNA, which are inherently fluorescent under physiological conditions, are identified and methods for their preparation provided. Such analogs may be incorporated into DNA and/or RNA oligonucleotides via either enzymatic or chemical synthesis to produce fluorescent oligonucleotides having prescribed sequences. Such analogous sequences may be identical to, or the analogous complement of, template or target DNA or RNA sequences to which the fluorescent oligonucleotides can be hybridized. Methods of preparing either RNA or DNA oligonucleotide probes of the invention, intermediates used in such methods, and methods of using the probes of the invention in oligonucleotide amplification, detection, identification, and/or hybridization assays are also provided.Type: GrantFiled: March 21, 1994Date of Patent: June 9, 1998Assignee: ChromagenInventor: Michael J. Conrad
-
Patent number: 5728525Abstract: Structural analogs of the six non-fluorescent N-nucleosides commonly found in RNA and DNA, which are inherently fluorescent under physiological conditions, are identified and methods for their preparation provided. Such analogs may be incorporated into DNA and/or RNA oligonucleotides via either enzymatic or chemical synthesis to produce fluorescent oligonucleotides having prescribed sequences. Such analogous sequences may be identical to, or the analogous complement of, template or target DNA or RNA sequences to which the fluorescent oligonucleotides can be hybridized. Methods of preparing either RNA or DNA oligonucleotide probes of the invention, intermediates used in such methods, and methods of using the probes of the invention in oligonucleotide amplification, detection, identification, and/or hybridization assays are also provided.Type: GrantFiled: June 2, 1995Date of Patent: March 17, 1998Assignee: Chromagen, Inc.Inventor: Michael J. Conrad